OGDEN, Utah--(BUSINESS WIRE)--Setpoint Systems (http://www.setpointusa.com), a leader in design and manufacture of custom lean automation solutions and manufacturing ...
SetPoint Medical today announced the first patients in Chicago have been treated with the SetPoint System, an FDA-approved neuroimmune modulation therapy for adults living with moderately-to-severely ...
The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis (RA). The ...
Credit: SetPoint Medical. The SetPoint System is a rechargeable neurostimulation device that is implanted on the vagus nerve. Treatment with the SetPoint System, a neuroimmune modulation device, was ...
SetPoint Medical to Present Data at ACR Convergence 2025 Demonstrating Sustained Efficacy and Safety for the SetPoint System to Treat Rheumatoid Arthritis Four presentations highlight 12-month ...
Hosted on MSN
Device Implanted in the Neck May Ease RA Symptoms
The FDA has approved the SetPoint System, a device implanted in the neck for relieving rheumatoid arthritis symptoms that aren’t adequately managed by medication. The device uses a daily low-voltage ...
SetPoint Medical has raised $140 million. This includes $25 million in the second tranche of its Series C financing, as well as $115 million in its Series D financing, co-led by Elevage Medical ...
Procedures performed by Dr. Webster Crowley mark a milestone for neuroimmune modulation therapy in the Midwest SetPoint Medical today announced the first patients in Chicago have been treated with the ...
An innovative new device calms inflammation by delivering a low-voltage jolt of electricity to the vagus nerve. The FDA has approved the SetPoint System, a device implanted in the neck for relieving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results